A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations – results of a prematurely terminated study

Abstract Background Studies have suggested the reduced effectiveness of vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections with high vancomycin minimum inhibitory concentrations. Alternative agents such as daptomycin may be considered. We conducted a randomi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shirin Kalimuddin, Yvonne F. Z. Chan, Rachel Phillips, Siew Pei Ong, Sophia Archuleta, David Chien Lye, Thuan Tong Tan, Jenny G. H. Low
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2018-06-01
coleção:	Trials
Assuntos:	Methicillin-resistant Staphylococcus aureus Vancomycin Daptomycin Minimum inhibitory concentration Bacteremia
Acesso em linha:	http://link.springer.com/article/10.1186/s13063-018-2702-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!